Actively Recruiting
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
Led by University of Washington · Updated on 2026-05-06
40000
Participants Needed
1
Research Sites
232 weeks
Total Duration
On this page
Sponsors
U
University of Washington
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the intervention participants and two comparison groups will be utilized: eligible Seattle EMS patients who opt not to go to the SASC and King County residents, outside of Seattle, who meet the same eligibility criteria. A comparative interrupted time series analysis is planned to study the main effectiveness outcomes. Seattle Fire EMS will assess, refer, and arrange transport for participants to the SASC. The SASC will offer an array of services including post-overdose monitoring, utilization of buprenorphine and methadone for the treatment opioid use disorder and opioid withdrawal, linkage to ongoing care for OUD, and provision of harm reduction services and supplies. The length of stay in the SASC will be limited to less than 24 hours. A continuous process improvement (CPI) approach will monitor and refine the intervention. Characterization of the interventions will be based upon analysis of service utilization patterns over time along with interviews and surveys with stakeholders.
CONDITIONS
Official Title
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Verbally consents to transfer of care to SASC.
- Awake and oriented to person and place, with no significant mental status or neurological deficits.
- Age 18 or older.
- Patent airway and effective breathing with adequate oxygen.
- Stable heart rate and blood pressure; no cardiac arrhythmias or significant cardiovascular problems.
- Vital signs within specified ranges: heart rate 45-130, systolic BP 95-190, diastolic BP 50-120, respiratory rate 10-24, SpO2 above 92% on room air or supplemental oxygen, EtCO2 below 50, temperature 95.5-100.3 F, blood glucose 60-300 if indicated.
- No signs of head trauma such as dizziness, vision problems, seizures, weakness, persistent headache, cerebrospinal fluid or blood leakage, or abnormal pupils.
- No signs of other traumatic injury or medical needs requiring immediate treatment.
- No signs of respiratory infection; COVID-19 screening applied.
You will not qualify if you...
- People under 18 years old.
- Those who do not meet SASC admission criteria.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Downtown Emergency Service Center's Overdose Recovery and Care Access Centers
Seattle, Washington, United States, 98104
Actively Recruiting
Research Team
A
Anthony S Floyd, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here